Skip to main content

PCR Simplify VettaFi Private Credit Strategy ETF

The Simplify VettaFi Private Credit Strategy ETF (PCR) seeks income and capital appreciation by investing in a private credit strategy plus a credit hedge derivatives strategy.

The private credit strategy focuses on business development companies (BDCs) and publicly-traded closed end funds (CEFs) that primarily invest in the private credit sector.

Credit hedging is primarily through a proprietary long/short hedge based on total return swaps of “quality” and “junk” equities.

Interested in more?

CONTACT US

Interested in more?

CONTACT US

Why Invest in PCR?

Attractive Monthly Income Potential

Private credit has the potential for significantly higher income than can be found in traditional fixed income investments

Focused on Income and Volatility

PCR seeks to approximate the VettaFi Private Credit Index, which targets higher yielding and lower volatility securities while incorporating a proprietary credit hedge to cushion downside

Operationally Efficient

PCR combines many of the benefits of private credit without the limited liquidity, high fees and K-1 tax reporting of traditional private credit vehicles
 

Fund Overview

As of 08/13/2026

Ticker Symbol
PCR
Expense Ratio
0.76%
CUSIP
82889N251
Total Assets
$2,519,852.95
Shares Outstanding
125,001
Distribution Rate as of 06/30/2026 Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
Distribution Rate Close
Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
11.77%
Distribution Frequency
Monthly
30-Day SEC Yield (Subsidized) as of 06/30/2026
2.87%
30-Day SEC Yield (Unsubsidized) as of 06/30/2026
2.87%
Options Available
No
Inception Date
09/22/2025
Premium/Discount (%) as of 08/13/2026
-0.09%
NAV Per Share as of 08/13/2026
$20.16
Market Price as of 08/13/2026
$20.14
30-Day Median Bid-Ask Spread
0.53%
Bid/Ask
$20.10/$20.21
Midpoint Price
$20.16
Volume
704
NAV Symbol
PCR.NV
IOPV Symbol
PCR.IV
Shares Out. Symbol
PCR.SO
Schedule K-1
No

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees0.75%
Distribution and Service (12b-1) Fees0.00%
Other Expenses10.00%
Acquired Fund Fees and Expenses20.01%
Total Annual Fund Operating Expenses0.76%

1. Other Expenses are estimated for the Fund’s initial fiscal year. 
2. Acquired Fund Fees and Expenses, which are estimated for the Fund’s initial fiscal year, are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.

Fund Performance (Total Return)

As of 07/31/2026 06/30/2026

Cumulative 1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year Since Inception
NAV -3.03% -8.04% -12.26% -12.33% -17.91%
Market Price -3.09% -8.06% -12.31% -12.96% -17.98%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV
Market Price
Cumulative 1 Year 3 Year 5 Year Since Inception
NAV -15.35%
Market Price -15.36%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV
Market Price

Growth of $10,000

The growth of $10,000 chart reflects a hypothetical investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted. Results are not indicative of future performance.

Historical Premium/Discount

Calendar Year 2025 2nd Quarter of 2026
Days Traded at Premium
61
33
Days Traded at Discount
9
29

Portfolio Holdings

Ticker Name Quantity Weight
TUA SIMPLIFY E SHORT TERM TRSRY FUTURES 23,740 19.33%
- TRS VPCIX SOFR +50 091526 3,699 102.27%
- TRS UBSMQTHT SOFR +25 111326 7,219 31.11%
- TRS UBSMPDLT SOFR -05 111326 662,864 26.31%
- TRS UBSMPDLT SOFR -05 111326 -5,127 -28.59%
- TRS UBSMQTHT SOFR +25 111326 -753,766 -29.91%
- TRS VPCIX SOFR +50 091526 -2,457,430 -97.52%
T Bills UNITED STS TREAS BILLS 0.0 15OCT26 200,000 7.89%
T Bills UNITED STS TREAS BILLS 0.0 31DEC26 1,730,000 67.66%
- Estimated Cash 36,691 1.46%

Recent Distributions

Ex-Dividend Date Record Date Payable Date Total Distribution
N/A
$0.19000
$0.19000
$0.19000
$0.19000
View Distribution History

Why Register?

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
Create Your Account
Simplify Curated Model Portfolios Incorporating Alternatives In-Depth Case Studies To Help You Manage Portfolios
Contact Us